Mitotic cdc2 Kinase and Alzheimer Neurodegeneration
Principal Investigator
Inez Vincent, PhD
Seattle Institute for Biomedical and Clinical Research
Seattle, WA, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$80,000
Active Dates
April 01, 1999 - March 31, 2001
Grant ID
A1999039
Summary
Dr. Vincent is exploring the hypothesis that some of the processes that cause cancer in dividing cells can also occur in non-dividing neurons. Because neurons cannot divide, these processes may lead to cell degeneration and cell death. She has already found that some of the proteins that are key to cell division and cell growth are present in the dying neurons of Alzheimer’s disease. These cell proteins are sometimes detectable in neurons even before the appearance of the lesions characteristic of AD. In this study, Dr. Vincent is testing whether introducing these cell cycle proteins into normal neurons will produce AD lesions. Once this question is answered, she will then attempt to determine if the known genetic mutations associated with AD affect the expression of the cell cycle proteins, and if so, how they do so.
Related Grants
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University